✦ LIBER ✦
Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial
✍ Scribed by Hitz, F.; Fischer, N.; Pabst, Th.; Caspar, C.; Berthod, G.; Eckhardt, K.; Berardi Vilei, S.; Zucca, E.; Mey, U.
- Book ID
- 120249883
- Publisher
- Springer
- Year
- 2013
- Tongue
- English
- Weight
- 160 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.